InvestorNewsBreaks – AOM Capital Completes $5.1 Million Financing for Therapeutics Company Acquisition

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AOM Capital announced the completion of a $5.1 million financing for a therapeutics company in connection with its acquisition of a pharmaceutical drug asset. The private investment and specialty bridge lending firm structured the financing around the specific requirements of the transaction, providing the capital needed to support the acquisition. AOM Capital said the transaction expands its activity in private credit, acquisition financing and special situations, with the firm focused on providing flexible capital for acquisitions, bridge transactions, growth initiatives and other complex or time-sensitive opportunities.

To view the full press release, visit https://ibn.fm/imbdB

About AOM Capital

AOM Capital is a private investment and specialty bridge lending firm providing customized capital solutions to companies, entrepreneurs and transaction sponsors. AOM Capital focuses on acquisition financing, private credit, bridge financing, growth capital and special situations across a range of industries.

The firm takes a transaction-focused approach to investing, seeking opportunities where flexible structuring, speed and certainty of execution can provide companies with the capital necessary to achieve their strategic objectives.

For more information, visit https://aomcap.com/

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  272.27
-5.82 (-2.09%)
AAPL  304.91
-3.35 (-1.09%)
AMD  474.32
+4.76 (1.01%)
BAC  64.00
+0.14 (0.22%)
GOOG  343.00
-12.84 (-3.61%)
META  599.12
+4.20 (0.71%)
MSFT  503.81
-2.25 (-0.44%)
NVDA  217.50
-0.05 (-0.02%)
ORCL  145.48
-5.57 (-3.69%)
TSLA  332.81
+1.93 (0.58%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.